@article{article_1004102, title={Comparison of Laboratory Findings And Mortalıty Rates of Varıant ALPHA and SARS-COV-2 Infected Patients}, journal={International Anatolia Academic Online Journal Health Sciences}, volume={7}, pages={79–88}, year={2021}, author={Keskin, Adem and Aci, Recai and Taşkın, Mehmet Hakan and Erdem, Mukadder and Bilgin, Melek and Arı, Murat}, keywords={Varyant Alfa, SARS-CoV-2, Ölüm Oranı, D-dimer, Protrombin Zamanı, C-reaktif protein}, abstract={In our study, the common laboratuvary findings affecting SARS-CoV-2 patient outcomes were designed on the levels detected in Variant Alpha patients. 115 Variant Alpha inpatients, 115 SARS-CoV-2 inpatients and 111 healthy individuals were included in this study. Variant Alpha White Blood Cell (WBC), Platelet, Neutrophil, Lymphocyte, Monocyte count, Neutrophil Lymphocyte Ratio(NLR), Monocyte Lymphocyte Ratio (MLR), Hemoglobin, Procalcitonin, C-reactive protein (CRP), Ferritin, Prothrombin Time (PT), activated Partial Thromboplastin Time (aPTT), International Normalized Ratio(INR), D-dimer levels and SARS-CoV-2 patients levels were compared. This comparison also includes comparison with the levels of healthy individuals. WBC, Neutrophil, MLR, NLR, PCT (p=0.037), Ferritin, CRP, aPTT, D-dimer levels of the Variant Alpha group were higher than the levels of SARS-CoV-2 group, and Lymphocyte (p=0.001), PT, INR levels of the Variant Alpha group were lower than the levels of SARS-CoV-2 group (p<0.001). There was no difference between the mortality rates observed in the Variant Alpha group and the SARS-CoV-2 group (p>0.05). In terms of laboratory findings, Variant Alpha patients experience more severe disease than SARS-CoV-2 patients. The reason that there was no difference in mortality rate between the groups may be the higher PT and INR values of the SARS-CoV-2 group.}, number={3}, publisher={Abdülkadir IŞIK}